Literature DB >> 17574348

p53 genotypes and haplotypes associated with risk of breast cancer.

Nur Buyru1, Julide Altinisik, Semra Demokan, Nejat Dalay.   

Abstract

INTRODUCTION: The biological significance of sequence variants in form of SNPs needs to be carefully evaluated, as conflicting associations with cancer predisposition have been reported. Haplotypes, the combination of closely linked alleles on a chromosome, play key roles in the study of the genetic basis of disease. There is strong evidence that different polymorphisms within a single gene in cis position can interact to create a large effect on the observed phenotype. Several polymorphisms have been reported in the p53 gene. Some of these are within the coding region and may affect the function of the p53 protein, others are within introns or non-coding regions, and their significance is unclear. In this study, we investigated the association of specific p53 genotypes and haplotypes with risk of breast cancer.
METHODS: One hundred and fifteen patients with breast cancer and 63 healthy individuals were analyzed. DNA was isolated by salting out. The polymorphic sites were analyzed by PCR RFLP. Pearson's chi(2) and Kolmogorof Simirnow tests were used for statistical analyses. Extended haplotype frequencies were estimated.
RESULTS: The distribution of the genotypes was similar for all three polymorphisms in the cases and the controls. Our estimated haplotype results indicate that the intron 3 (+16bp)|exon 4 (Arg) diplotype and the intron 3 (+16bp)|exon 4 (Arg)|intron 6 (G) haplotype combinations are overrepresented in the breast cancer group, suggesting that the intron 3 (+16bp)|exon 4 (Arg) alleles may play a role in breast carcinogenesis.
CONCLUSION: We conclude that two haplotypes harboring the intron 3 polymorphic (+16bp) allele are associated with a higher risk of breast cancer in the Turkish population.

Entities:  

Mesh:

Year:  2007        PMID: 17574348     DOI: 10.1016/j.cdp.2007.04.004

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  11 in total

1.  P53 gene polymorphisms and breast cancer risk in Arab women.

Authors:  Shafika Alawadi; Lina Ghabreau; Mervat Alsaleh; Zainab Abdulaziz; Mohamed Rafeek; Nizar Akil; Moussa Alkhalaf
Journal:  Med Oncol       Date:  2010-05-05       Impact factor: 3.064

2.  p53 Codon 72 arginine/proline polymorphism and cancer in Sudan.

Authors:  Huda A Eltahir; Ameera A M Adam; Zeinab A Yahia; Noon F Ali; Dalia M Mursi; Ashraaf M Higazi; Nahid A Eid; Ahmed M Elhassan; Hiba S Mohammed; Muntaser E Ibrahim
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

3.  Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.

Authors:  Roghayeh Dehghan; Mohammad Ali Hosseinpour Feizi; Nasser Pouladi; Esmaeil Babaei; Vahid Montazeri; Ashraf Fakhrjoo; Ayda Sedaei; Parvin Azarfam; Masoumeh Nemati
Journal:  Pathol Oncol Res       Date:  2014-11-20       Impact factor: 3.201

4.  Intron 3 sixteen base pairs duplication polymorphism of p53 contributes to breast cancer susceptibility: evidence from meta-analysis.

Authors:  Dongmei Wu; Zhizhong Zhang; Haiyan Chu; Ming Xu; Yao Xue; Haixia Zhu; Zhengdong Zhang
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

5.  Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis.

Authors:  Meire Luzia Gonçalves; Sarah Moreira Borja; Jacqueline Andréia Bernardes Leão Cordeiro; Vera Aparecida Saddi; Flávio Monteiro Ayres; Cesar Augusto Sam Tiago Vilanova-Costa; Antonio Márcio Teodoro Cordeiro Silva
Journal:  Springerplus       Date:  2014-12-17

6.  Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia.

Authors:  Ming Li; Dapeng Wang; Yumin Wang; Guili Sun; Wanli Song; Bin Zhang; Burenbatu Borjigin
Journal:  Oncol Lett       Date:  2017-06-13       Impact factor: 2.967

7.  Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Oumar Kassogue; Mamadou Lassine Keita; Brian Joyce; Erin Neuschler; Jun Wang; Jonah Musa; Cheick Bougari Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Mercy Isichei; Jane L Holl; Robert Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-07-03       Impact factor: 2.103

8.  Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

Authors:  Chaymaa Marouf; Amal Tazzite; Brehima Diakité; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Tumour Biol       Date:  2014-09-09

9.  A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.

Authors:  Paola Gallì; Gabriella Cadoni; Mariangela Volante; Emma De Feo; Rosarita Amore; Arianna Giorgio; Dario Arzani; Gaetano Paludetti; Gualtiero Ricciardi; Stefania Boccia
Journal:  BMC Cancer       Date:  2009-05-08       Impact factor: 4.430

10.  Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.

Authors:  Juliana G Assumpção; Ana Luíza Seidinger; Maria José Mastellaro; Raul C Ribeiro; Gerard P Zambetti; Ramapriya Ganti; Kumar Srivastava; Sheila Shurtleff; Deqing Pei; Luiz Carlos Zeferino; Rozany M Dufloth; Silvia Regina Brandalise; José Andres Yunes
Journal:  BMC Cancer       Date:  2008-12-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.